M&A Forum Japan 2024

The premier M&A forum in Japan

location_on The Conrad, Tokyo, Minato City Map
25 Jun

Cross-border deals: Navigating the markets

Overseas buying has caught the attention of investors, both inbound and outbound, as business owners increase their appetite for engaging in cross-border M&A. Japan is a hotspot for inbound investment as the country has a large pool of solid assets, simultaneously, out-bound deals are also recovering with the opportunity for value creation and overseas expansion. On the other hand, there are long-terms challenges that remain such as an aging population, questions marks on if and when non-core divestitures will happen, ability for overseas investors to gain traction curtailing the growth momentum, and geopolitical issues. Our panel of experienced investors and dealmakers outline the driving forces for cross-border activity, including the hotspots in the Japanese market.

  • How are companies integrating domestic & overseas operations to establish global management systems and structures?
  • How do you navigate the cultural aspects of integration and drive value creation? 
  • Increase in carve out deals. What are difficulties that non-Japanese buyers typically face in these transactions? 
  • More hostile takeover cases in Japanese market recently. What are key areas buyer needs to be mindful about? 
  • Increase in the acquisition of early stage/start up business in Japanese market… What are key areas buyers need to be aware of?
image image image image image image
  • Speakers keyboard_arrow_down
    image
    Jonathan Wallace Managing Director MITSUBISHI UFJ MORGAN STANLEY SECURITIES Bio
    image
    Guy Wallace Director, Corporate Development SONY Bio
    image
    Joseph Fisher Partner HERBERT SMITH FREEHILLS GJBJ Bio
    image
    Norio Shibayama Principal and Head of M&A Advisory Services, Tokyo MERCER Bio
    image
    Ken Matsuda Senior Manager, Corporate Strategy KIRIN HOLDINGS Bio
    image
    Cem Goekmen Global Head of Corporate Development ADRAGOS PHARMA Bio
Language: English 日本語

Loading feed